Close Menu

CHICAGO (GenomeWeb) – Genome informatics vendor DNAnexus said today that it will support the AstraZeneca Centre for Genomics Research in its efforts to analyze as many as 2 million genomes over the next 10 years in the name of more precise drug discovery.

Financial terms were not disclosed.

Under the agreement, Mountain View, California-based DNAnexus indicated that it would work with AstraZeneca to develop a "secure genomics informatics environment" to manage the wide-scale sequencing analytics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe is offering early customers re-testing on newer chips for a fee, Wired reports.

He Jiankui is no longer affiliated with Direct Genomics Biotechnology, the single molecule sequencing company he founded, Nikkei Asian Review reports.

Newsweek writes about the hopes for precision medicine in cancer, but also challenges getting it to patients.

In Genome Research this week: genomic architecture of glioblastoma, predictive computational approach to estimate SNP fitness, and more.